N🟁N

NPS Pharmaceuticals to Present at Needham Healthcare Conference

  //health-fitness.news-articles.net/content/2011/ .. to-present-at-needham-healthcare-conference.html
  Published in Health and Fitness on Thursday, March 31st 2011 at 5:30 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

BEDMINSTER, N.J.--([ BUSINESS WIRE ])--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the 10^th Annual Needham Healthcare Conference in New York on Wednesday, April 6, 2011 at 10:00 a.m. ET. The presentation will be available as a live webcast with a replay available approximately three hours after the presentation has concluded. Interested parties may access the webcast from the investorsa™ calendar of events page on the NPS website at [ http://www.npsp.com/events ].

About NPS Pharmaceuticals

NPS Pharmaceuticals is an outsourcing-based development company focused on bringing biopharmaceuticals to patients with rare disorders and few, if any, therapeutic options. The company is advancing two Phase 3 registration programs, GATTEX® (teduglutide) in short bowel syndrome (SBS) and NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) in hypoparathyroidism. NPS complements its proprietary programs with a royalty-based portfolio of products and product candidates that includes agreements with Amgen, Kyowa Hakko Kirin, Nycomed, and Ortho-McNeil Pharmaceutical.